Bone Microcirculation After Extracorporeal Shock Wave Therapy
Intact Scaphoid Bone, Intact Metacarpal Bone, Fractured Scaphoid Bone
About this trial
This is an interventional basic science trial for Intact Scaphoid Bone
Eligibility Criteria
Inclusion Criteria:
- Group A (n=20): Consent-capable male and female patients ≥18 years of age who have an intact scaphoid.
- Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone.
- Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid.
- Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone.
Exclusion Criteria:
- below 18 years of age
- scar tissue above scaphoid or metacarpal bone
- osteoporosis or comparable bone disease
- medication that influences bones
Sites / Locations
- University of Schleswig-Holstein
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Experimental
Experimental
Experimental
Experimental
Experimental
Intact scaphoid bone
Intact metacarpal bone
Fractured scaphoid bone
Fractured metacarpal bone
Intact metatarsal bone
Group A (n=20): Consent-capable male and female patients ≥18 years of age who have an intact scaphoid. Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)
Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone. Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)
Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid. Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)
Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone. Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)
Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metatarsal bone. Intervention: Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)